The process of drug discovery and development, often stretching over decades, is one of the most demanding and expensive tasks faced by the pharmaceutical industry. Recently, Artificial Intelligence (AI) has emerged as a promising tool to streamline this process, promising dramatic reductions in
Amidst advancing medical treatments for colorectal cancer, a less-discussed byproduct of the disease is its profound impact on women's sexual health. This emerging issue is gaining attention as researchers endeavor to understand how female survivors cope with post-treatment sexual challenges.
The prevalence of diabetes presents an escalating health crisis with significant implications for individuals and healthcare systems globally. Among prediabetes patients, effective prevention strategies are vital to curb the increasing rates of Type 2 diabetes. Long-term studies underscore that
Ivan Kairatov, a notable expert in biopharma with a rich background in tech and innovation within the industry, lends his insights on a recent groundbreaking study in human cell cycle regulation. The study, led by the team at EPFL, unveils how newly evolved genes are integral to the complex process
Personalized diets are emerging as a beacon of hope in the complex world of food sensitivity research, offering potential solutions to a pervasive and intricate problem. Food sensitivities, distinct from well-known allergies, are linked to immune responses involving IgA and IgG antibodies. These
In a groundbreaking advancement in cellular biology, scientists at the University of Virginia School of Medicine and the NIH have uncovered a previously unknown organelle, named the hemifusome. This advancement promises profound impacts on understanding and potentially treating complex genetic
